68885-32-5 Usage
General Description
(4-chlorophenyl)(pyridin-3-yl)Methanol is a chemical compound with a molecular formula C12H10ClNO. It is a white to off-white crystalline powder that is commonly used as an intermediate in the production of pharmaceuticals and agrochemicals. The compound is also used as a building block in the synthesis of various organic compounds. It has a chlorophenyl group and a pyridinyl group attached to a methanol moiety, making it a versatile molecule for the synthesis of new materials and bioactive compounds. The compound has potential applications in the development of new drugs and agrochemicals due to its unique structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 68885-32-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,8,8 and 5 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 68885-32:
(7*6)+(6*8)+(5*8)+(4*8)+(3*5)+(2*3)+(1*2)=185
185 % 10 = 5
So 68885-32-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H10ClNO/c13-11-5-3-9(4-6-11)12(15)10-2-1-7-14-8-10/h1-8,12,15H
68885-32-5Relevant articles and documents
Pyridine-directed asymmetric hydrogenation of 1 1-diarylalkenes
Yang, Hailong,Wang, Erfei,Yang, Ping,Lv, Hui,Zhang, Xumu
supporting information, p. 5062 - 5065 (2017/11/07)
Highly enantioselective pyridine-directed rhodium-catalyzed asymmetric hydrogenation of challenging 1 1-diarylalkenes is achieved by using [Rh(NBD)DuanPhos]BF4 as a precatalyst. Various types of 2-pyridine substituted 1 1-diarylalkenes could be hydrogenated with good to excellent enantioselectivities which provide an efficient route to the synthesis of pharmaceutically and biologically active compounds containing a 2-pyridyl ethane unit.
Azetidine derivatives, their preparation and pharmaceutical compositions containing them
-
, (2008/06/13)
Compounds of formula: in which R represents a CR1R2, C═C(R5)SO2R6 or C═C(R7)SO2alk radical, their preparation and the pharmaceutical compositions containing them.
